id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-258722-1o6zhnnj	Gbinigie, Kome	Should azithromycin be used to treat COVID-19? A rapid review	2020-05-13		.txt	text/plain	3320	193	50	In vivo and in vitro studies were included assessing the safety and effectiveness of azithromycin for treatment of COVID-19, and/or the activity of azithromycin against SARS-CoV-2. In another pre-print, Andreania and colleagues 13 report the results of an in vitro study assessing the activity of azithromycin and hydroxychloroquine against SARS-CoV-2. In vivo research effectiveness Only one trial was identified on the effectiveness of azithromycin for the treatment of COVID-19, conducted by Gautret and colleagues in France and reported in a pre-print 14 (see Table 1 ). The same research team that conducted the in vivo study included in this review conducted a singlearm trial of 80 patients who tested positive for SARS-CoV-2 and showed mild symptoms, 17 to further assess the effectiveness of the combined hydroxychloroquine/azithromycin treatment regime. No in vivo studies were identified assessing the safety or effectiveness of azithromycin as a standalone treatment for COVID-19.	./cache/cord-258722-1o6zhnnj.txt	./txt/cord-258722-1o6zhnnj.txt